ADNI Scientists

ADNI Publications
ADNI Data and Publications Committee
Robert C. Green, MD, MPH - DPC Chair
Email: rcgreen@genetics.med.harvard.edu

Erin H. Klopfenstein - DPC Coordinator
Email: edrake@genetics.med.harvard.edu

Questions for the DPC may be emailed directly to Erin Klopfenstein.

If you are interested in applying for access to ADNI data, you can do so via the online application here .

If you have prepared a manuscript utilizing ADNI data, please submit it for review by the ADNI DPC before submitting to a journal for peer review and publication, by emailing it to Erin Klopfenstein.


ADNI Publications


Year
Citation
Abstract
2011
Abdulkadir A, Mortamet B, Vemuri P, Jack CR Jr, Krueger G, Kloopel S, The Alzheimer's Disease Neuroimaging Initiative: Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier. Neuroimage, 58:785-792, 2011.
 
2011
Antunez C, Boada M, Gonzalez-Perez A, Gayan J, Ramirez-Lorca R, Marin J, Hernandez I, Moreno-Rey C, Moron FJ, Lopez-Arrieta J, Mauleon A, Rosende-Roca M, Noguera-Perea F, Legaz-Garcia A, Vivancos-Moreau L, Velasco J, Carrasco JM, Alegret M, Antequera-Torres M, Manzanares S, Romo A, Blanca I, Ruiz S, Espinosa A, Castano S, Garcia B, Martinez-Herrada B, Vinyes G, Lafuente A, Becker JT, Galan JJ, Serrano-Rios M; The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's Disease. Genome Med. 3:33, 2011.
 
2011
Antunez C, Boada M, Lopez-Arrieta J, Moreno-Rey C, Hernandez I, Marin J, Gayan J, Alzheimer's Disease Neuroimaging Initiative, Gonzalez-Perez A, Real LM, Alegret M, Tarraga L, Ramirez-Lorca R, Ruiz A: Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease. Alzheimer's Dementia, 7:e124-e129, 2011.
 
2011
Bakken TE, Dale AM, Schork NJ: A geographic cline of skull and brain morphology among individuals of European ancestry. Human Heredity, 72:35-44, 2011.
 
2011
Bonner-Jackson A, Okonkwo O, Tremont G, and the Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E e2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. American Journal of Geriatric Psychiatry, epub ahead of print, 2011.
 
2011
Bossa M, Zacur E, Olmos S and the ADNI: Statistical analysis of relative pose information of subcortical nuclei: Application on ADNI data. Neurimage.55:999-1008, 2011.
 
2011
Brown PJ, Devanand DP, Liu X, Caccappolo E, Alzheimer's Disease Neuroimaging Initiative: Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry, 68:617-626, 2011.
 
2011
Cardoso MJ, Clarkson MJ, Ridgway GR, Modat M, Fox NC, Ourselin S, the Alzheimer's Disease Neuroimaging Initiative: LoAd: A locally adaptive cortical segmentation algorithm. Neuroimage. 56:1386-1397, 2011
 
2011
Chaing GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr, Weiner MW, Alzheimer's Disease Neuroimaging Initiative: Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology, 259:844-851, 2011.
PMC3099048  View
2011
Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative: Characterizing Alzheimer’s Disease Using a Hypometabolic Convergence Index. Neuroimage, 56:52-60, 2011.
PMC3066300  View
2011
Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Oliveri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F, The Alzheimer's Disease Neuroimaging Initiative: Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage, 58:469-480, 2011.
 
2011
Cover KS, van Schijndel RA, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H, neuGRID, the Alzheimer's Disease Neuroimaging Initiative: Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-Rage MRI scans. Psychiatry Res, 193:182-190, 2011.
 
2011
Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park M, Jiang T, Jin JS, the Alzheimer's Disease Neuroimaging Initiative: Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One, 6:e21896, 2011.
PMC3140993  View
2011
Cuingnet R, Rosso C, Chupin M, Lehericy S, Dormont D, Bennal H, Samson Y, Colliot O: Spatial regularization of SVM for the detection of diffusion alterations associated with stroke outcome. Med Image Anal, 15(5):729-37, 2011.
 
2011
Dickerson BC, Wolk DA; the Alzheimer's Disease Neuroimaging Initiative. Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry. 82:45-51, 2011.
PMC3023235  View
2011
Donohue MC, Gamst AC, Thomas RG, Xu R, Beckett L, Petersen RC, Weiner MW, Aisen P; for the Alzheimer's Disease Neuroimaging Initiative. The relative efficiency of time-to-threshold and rate of change in longitudinal data. Contemp Clin Trials.32:685-693, 2011.
PMC3148349  View
2011
Dukart J, Mueller K, Horstmann A, Barthel H, Mooler HE, Villringer A, Sabri O, Schroeter ML: Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.PLoS One, 6:e18111, 2011.
PMC3063183  View
2011
Dukart J, Schroeter ML, Mueller K, The Alzheimer's Disease Neuroimaging Initiative: Age correction in dementia - Matching to a healthy brain. PLoS One, 6:e22193, 2011.
PMC3146486  View
2011
Erten-Lyons D, Wilmot B, Anur P, McWeeney S, Westaway SK, Silbert L, Kramer P, Kaye J: Microcephaly genes and risk of late onset Alzheimer Disease. Alzheimer Dis Assoc Disord. 25:276-282, 2011.
PMC3136560  View
2011
Ewers M, Schmits S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Monthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Tiepel SJ, Weiner M, Hampel H, Alzheimer's Disease Neuroimaging Initiative: Body mass index is assocaited with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiology of Aging, epub ahead of print, 2011.
 
2011
Filipovych R, Davatzikos C for the ADNI: Semi-supervised pattern classification of medical images: Application to mild cognitive impairment (MCI). Neuroimage. 55:1109-1119, 2011.
PMC3049826  View
2011
Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; for the Alzheimer's Disease Neuroimaging Initiative: Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of General Psychiatry, 68: 961-969, 2011.
 
2011
Heckemann RA, Keihaninejad S, Aljabar P, Gray KR, Neilsen C, Rueckert D, Hajnal JV, Hammers A, the ADNI: Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage. 56:2024-2037, 2011.
PMC3153069  View
2011
Herholz K, Westwood S, Haense C and Dunn G: Evaluation of a calibrated F-FDG PET score as a biomarker for progression in Alzheimer disease and Mild Cognitive Impairment. Journal of Nuclear Medicine, 52:1218-1226, 2011.
 
2011
Hibar DP, Stein JL, Kohannim O, Jahanshad N, Saykin AJ, Shen L, Kim S, Pankratz N, Foroud T, Huentelman MJ, Potkin SG, Jack CR Jr, Weiner MW, Toga AW, Thompson PM, the Alzheimer’s Disease Neuroimaging initiative. Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 56:1875-1891, 2011.
 
2011
Hinrichs C, Singh V, Xu G, Johnson SC, The ADNI: Predicitve markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population. Neuroimage. 55:574-589, 2010.
PMC3035743  View
2011
Holland D, Dales A and the ADNI: Nonlinear Registration of Longitudinal Images and Measurement of Change in Regions of Interest. Medical Image Analysis.4:489-497, 2011.
PMC3115407  View
2011
Holland D, McEvoy LK, Dale AM, the Alzheimer's Disease Neuroimaging Initiative: Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Human Brain Mapping, epub ahead of print, 2011.
 
2011
Hu X, Pickering E, Liu YC, Hall S, Fournier H, Dechairo B, John S, Van Eerdewegh PV, Soares H, the ADNI: Meta-analysis for Genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer’s disease. PLOS ONe. 6: e16616, 2011.
PMC3044719  View
2011
Hua X, Gutman B, Boyle CP, Rajagopalan P, Leow AD, Yanovsky I, Kumar AR, Toga AW, Jack CR Jr., Schuff N, Alexander GE, Chen K, Reiman EM, Weiner MW, Thompson PM, the Alzheimer's Disease Neuroimaging Initiative: Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage. 57:5-14, 2011.
PMC3115407  View
2011
Illan IA, Gorriz JM, Ramirez J, Salas-Gonzalez D, Lopez MM, Segovia F, Chaves R, Gomez-Rio M, Puntonet CG, the ADNI: 18F-FDG PET Imaging for computer aided Alzheimer’s diagnosis. Information Sciences. 181: 903-916, 2011.
 
2011
Jennings JR, Mendelson DN, Muldoon MF, Ryan CM, Gianaros PJ, Raz N, Aisenstein H: Regional grey matter shrinks in hypertensive individuals despide successful lowering of blood pressure. Journal of Human Hypertension, epub ahead of print, 2011.
PMC3137674  View
2011
Kauwe JSK, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtman DM, Morris JC, ADNI, Goate AM: Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM. Plos One. 6: e15918, 2011.
PMC3036586  View
2011
Kim S, Swaminathan S, Shen L et al.: Genome-wide association study of CSF biomarkers Ab1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 76: 69-79, 2011.
PMC3030225  View
2011
Koikkalainen J, Laotjaonen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H, the Alzheimer's Disease Neuroimaging Initiative. Multi-template tensor-based morphometry: Application to analysis of Alzheimer's disease. Neuroimage, 56, 1134-1144, 2011.
 
2011
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM et al: Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging, 32:1207-1218, 2011.
PMC2891865  View
2011
Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S, the ADNI: Brain MAPS: An automated, accurate and robust brain extraction technique using a template library. Neuroimage, 55:1091-1108, 2011.
 
2011
Li Y, Wang Y, Wu G, Shi F, Zhou L, Lin W, Shen D, The ADNI: Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiology of Aging. Epub ahead of print, 2011.
PMC3086988  View
2011
Llano DA, Laforet G, Devanarayan V, ADNI: Derivation of a new ADAS-cog Composite Using Tree-based Multivariate Analysis: Prediction of Conversion From Mild Cognitive Impairment to Alzheimer Diseaes. Alz. Dis. Assoc. Disord. 25:73-84, 2011
 
2011
Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Arch Neurol. Longitudinal Change of Biomarkers in Cognitive Decline. Epub ahead of print, 2011.
 
2011
Lopez M, Ramirez J, Gorriz JM, Alvarez I, Salas-Gonzalez D, Segovia F, Chaves R, Padilla P, Gomez-Rio M, and the ADNI: Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer’s disease. Neurocomputing. 74: 1260-1271, 2011.
 
2011
Lötjönen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, Waldemar G, Soininen H, Rueckert D; The Alzheimer's Disease Neuroimaging Initiative: Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer’s disease. Neuroimage. 56, 185-196, 2011.
 
2011
Mackin RS, Insel P, Aisen PS, Geda YE, Weiner MW: Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: Relationship to conversion to dementia after 3 years. International Journal of Geriatric Psychiatry, epub ahead of print, 2011.
 
2011
Markiewicz PJ, Matthews JC, Declerck J, Herholz K, for the Alzheimer's Disease Neuroimaging Initiative. Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage, 56:1382-1385, 2011.
 
2011
Marshal GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA, Alzheimer's Diease Neuroimaing Initiative: Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia, 7:300-308, 2011.
PMC3096844  View
2011
Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, Sperling RA, Johnson KA, Alzheimer's Disease Neuroimaging Initiative: Instrumental activities of daily living impairment is associated with increased amyloid burden. Dementia and Geratric Cognitive Disorders, 31:443-450, 2011..
PMC3150869  View
2011
Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldermar G, Soininen H, Lotjonen J: A disease state fingerprint for evaluation of Alzheimer's disease. Journal of Alzheimer's Disease, epub ahead of print, 2011.
 
2011
Murphy EA, Roddey JC, McEvoy LK, Holland D, Hagler DJ Jr, Dale AM, Brewer JB, Alzheimer's Disease Neuroimaging Initiative: CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging Behavior, epub ahead of print, 2011.
 
2011
Pachauri D, Hinrichs C, Chung M, Johnson S, Singh V: Topology based Kernels with application to inference problems in Alzheimer's disease. IEEE Trans Med Imaging. 30:1760-70, 2011.
 
2011
Padilla P, Gorriz J, Ramirez J, Salas-Gonzalez D, Illan I: NMF-SVM Based CAD Tool Applied to Functional Brain Images for the Diagnosis of Alzheimer's Disease, IEEE Trans Med Imaging. 2011
 
2011
Park H, Seo J and the ADNI: Application of Multidimensional Scaling to Quantify Shape in Alzheimer’s Disease and Its Correlation with Mini Mental State Examination: A Feasibility Study. Journal of Neuroscience Methods. 15: 380-385, 2011.
 
2011
Pelaez-Coca M, Bossa M, Olmos S and the ADNI: Discrimination of AD and normal subjects from MRI: Anatomical versus statistical regions. Neuroscience Letters. 487: 113-117, 2011.
 
2011
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative: Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry Res. 194:7-13, 2011
PMC3185127  View
2011
Rajagopalan P, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport. 391-5, 2011.
 
2011
Samanti MN, Farnum M, Lobanov V, Yang E, Raghavan N, DiBernardo A, Narayan V, and the Alzheimer's Disease Neuroimaging Initiative: An improved model for disease progression in subjects from Alzheimer's Disease Neuroimaging Initiative. Journal of Clinical Pharmacology, epub ahead of print, 2011.
 
2011
Schmand B, Eikelenboom P, van Gool WA, the Alzheimer's Disease Neuroimaging Initiative: Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. Journal of the American Geriatric Society, epub ahead of print, 2011.
 
2011
Schneider LS, Insel PS, Weiner MW and the ADNI: Treatment with Cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neuro. 68: 58-66, 2011.
 
2011
Schott JM, Adni Investigators. Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging, Epub ahead of print, 2011.
PMC3150628  View
2011
Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ, the Alzheimer's Disease Neuroimaging Initiative: Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol. 5:597-609, 2011.
PMC3175107  View
2011
Shen L, Kim S, Qi Y, Inlow M, Swaminathan S, Nho K, Wan J, Risacher S, Shaw L, Trojanowski J, Weiner M, Saykin A, ADNI. Identifying neuroimaging and proteomic biomarkers for MCI and AD via the elastic net. MBIA 2011: International Workshop on Multimodal Brain Image Analysis (MBIA), Sept. 18, 2011, Toronto, Canada.
 
2011
Silver M, Montana G, Nichols TE, the ADNI: False positives in neuroimaging genetics using voxel-based morphometry data. NeuroImage. 54: 992-1000, 2011.
PMC3063336  View
2011
Skup M, Zhu H, Wang Y, Giovanello KS, Lin JA, Shen D, Shi F, Gao W, Lin W, Fan Y, Zhang H, the Alzheimer's Disease Neuroimaging Initiative: Sex differences in grey matter atrophy patterns among AD and MCI patients: Results from ADNI. Neuroimage. 56:890-906, 2011.
PMC3085726  View
2011
Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE, Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology, 258:843-852, 2011.
 
2011
Spiegel R, Berres M, Miserez AR, Monsch AU, the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Res Ther.3:9, 2011.
 
2011
Stricker NH, Chang YL, Fennema-Notestine C, Delano-Wood L, Salmon DP, Bondi MW, Dale AM, for the Alzheimer's Disease Neuroimaging Initiative: Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease. Neurology, 77:713-721, 2011.
PMC3164395  View
2011
Swaminathan S, Kim S, Shen L, Risacher SL, Foroud T, Pankratz N, Potkin SG, Huentelman MJ, Craig DW, Weiner MW, Saykin AJ, and the Alzheimer's Disease Neuroimaging Initiative: Genomic copy number analysis in Alzheimer's disease and MCI: An ADNI Study. International Journal of Alzheimer's Disease, epub ahead of print, 2011.
PMC3109875  View
2011
Swaminathan S, Shen L, Risacher SL, Yoker KK, West JD, Kim Sungeun, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, Sayking AJ, the Alzheimer's Disease Neuroimaging Initative (ADNI): Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, Brain Imaging and Behavior, epub ahead of print, 2011.
 
2011
Thompson WK, Hallmayer J, O'Hara R, Alzheimer's Disease Neuroimaging Initiative: Design considerations fro characterizing psychiatric trajectories across the lifespan: Application to effects of APOE e4 on cerebral cortical thickness in Alzheimer's disease. American Journal of Psychiatry, 168:894-903, 2011.
 
2011
Thomson WK, Holland D, the Alzheimer's Disease Neuroimaging Initiative: Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates. Neuroimage, 57:5-14, 2011.
 
2011
Tractenberg RE, Pietrzak RH: Intra-individual variability in Alzheimer's disease and cognitive aging: Definitions, context, and effect sizes. PLoS One, 6:e16973, 2011.
PMC3079725  View
2011
Wang H, Nie F, Huang H, Risacher SL, Ding C, Saykin AJ, Shen L. A new sparse multi-task regression and feature selection method to identify brain imaging predictors for memory performance. ICCV 2011: IEEE Conference on Computer Vision, November 6-13 2011, Barcelona, Spain.
 
2011
Weiner MW, Veitch DP, Aisen PS, Becket LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ and the Alzheimer's Disease Neuroimaging Initiative: The Alzheimer's Disease Neuoimaging Initiative: A review of papers published since its inception. Alzheimer's and Dementia, in press.
 
2011
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO, for the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative: AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classifiation accuracy in Europe and North America. Neuroimage, 58:818-828, 2011.
 
2011
Wolk DA, Dickerson BC, ADNI: Fractionating verbal episodic memory in Alzheimer's disease. Neuroimage, 54:1530-1539, 2011
PMC2997155  View
2011
Yang W, Lui RL, Gao JH, Chan TF, Yau ST, Sperling RA, Huang X: Independent component analysis-based classification of Alzheimer's disease MRI data, Journal of Alzheimer's Disease, 24:775-785, 2011
 
2011
Yesavage JA, Noda A, Hernandez B, Friedman L, Cheng JJ, Tinkleberg JR, Hallmayer J, O'hara R, David R, Robert P, Landsverk E, Zeitzer JM, the Alzheimer's Disease Neuroimaging Initiative: Cicadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer's disease. American Journal of Geriatric Psychiatry, 19:635-643, 2011
PMC3128424  View
2011
Zhang D, Wang Y, Zhou L, Yuan H, Shen D, and the ADNI: Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage. 55:856-867, 2011.
PMC3057360  View
2011
Zhang T, Davatzikos C: ODVBA: Optimally-discriminiative voxel-based analysis. IEEE Trans Med Imaging, 30:1441-1454, 2011.
 
2010
Andrawis JP, Hwang KS, Green AE, Kotlerman J, Elashoff D, Morra JH, Cummings JL, Toga AW, Thompson PM, Apostolova LG: Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiology of Aging. Epub ahead of print, 2010.
PMC3010297  View
2010
Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM, the ADNI: 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging. 31: 1284-1303, 2010.
PMC3051831  View
2010
Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR, Jr., Weiner MW, Thompson PM, and the ADNI: Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage. 51: 488-499, 2010.
PMC2847034  View
2010
Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, Kuo JH; Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimers Dement. May; 6(3):257-64, 2010.
PMC2867839  View
2010
Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmansky N, Salat D, Rosan J, for the ADNI: Genetic Variation and Neuroimaging Measures in Alzheimer disease. Archives in Neurology. 67: 677-685, 2010.
PMC2956757  View
2010
Bossa M, Zacur E, Olmos S, Alzheimer's Disease Neuroimaging Initiative. Tensor-based morphometry with stationary velocity field diffeomorphic registration: Application to ADNI. Neuroimage, Jul 51(3):956-69, 2010.
PMC3068621  View
2010
Cairns NJ, Taylor-Reinwald L, Morris JC; Alzheimer's Disease Neuroimaging Initiative. Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. Alzheimers Dement. 2010 May; 6(3):274-9.
PMC2893399  View
2010
Carmicahel O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR, Weiner M, DeCarli C, and the ADNI: Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer Disease Neuroimaging Initiative. Archives of Neurology. 67: 1370-1378, 2010.
PMC3082636  View
2010
Caroli A, Frisoni GB, The ADNI: The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Inititative cohort. Neurobiology of Aging. 31: 1263-1274, 2010.
 
2010
Chang Y-L, Bondi MW, Fennema-Notestine C, McEvoy LK, Hagler DJ, Jacobson MW, Dale AM, the Alzheimer’s Disease Neuroimaging Initiative: Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer’s disease. Neuropsychologia, 48: 1237-1247, 2010.
PMC2851550  View
2010
Chang YL, Jacobson MW, Fennema-Notestine C, Hagler DJ, Jennings RG et al: Level of executive function influences verbal memory in amnestic mild congnitive impairment and predicts prefrontal and posterior thickness. Cereb Cortex, 20: 1305-1313, 2010.
PMC2912652  View
2010
Chen K, Langbaum JBS, Fleisher AS, Ayutyanot N, Rescke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, deLeon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM, and ADNI: Twelve-month metabolic declines in probably Alzheimer’s disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region of interest: Findings from the Alzheimer’s Disease Neuroimaging Initiative. Neuroimage, 51: 654-664, 2010.
PMC2856742  View
2010
Chen W, Song X, Zhang Y, Darvesh S, Ningnannan Z, D'Arcy R, Black S, Rockwood K: An MRI-Based Semiquantitative Index for the Evaluation of Brain Atrophy and Lesions in Alzheimer’s Disease, Mild Cognitive Impairment and Normal Aging. Dement. And Geri Cog Disord. 30: 121-130, 2010.
PMC2969164  View
2010
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptensetang ST, Jack CR, Aisen PS, Petersen RC, Weiner MD, and the ADNI: Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normals. Neurology. 75: 1976-1981, 2010.
PMC3014234  View
2010
Chou YY, Lepore N, Saharan P, Madsen SK, Hua X, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM, and the ADNI: Ventricular maps in 804 ADNI subjects: Correlations with CSF biomarkers and clinical decline. Neurobiology of Aging. 31: 1386-1400, 2010.
PMC2904619  View
2010
Cronk BB, Johnson DK, Burns JM, and the Alzheimer’s Disease Neuroimaging Initiative: Body Mass Index and Cognitive Decline in Mild Cognitive Impairment. Alzheimer’s Disease & Associated Disorders, 24: 126-130, 2010.
PMC3068614  View
2010
Cuingnet R, Chupin M, Benali H, Colliot O: Spatial prior in SVM-based classification of brain images. SPIE. 7624: 76241L-76241L-9, 2010.
 
2010
Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehericy S, Habert MO, Chupin M, Benali H, Colliot O, and the ADNI: Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of then methods using the ADNI database. Neuroimage. 56(2):766-781. 2010.
 
2010
Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ: Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiology in Aging. Epub ahead of print, 2010.
PMC2951483   View
2010
De Meyer G, Shapior F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ, the ADNI: Diagnosis-Independent Alzheimer disease biomarker signature in cognitively normal elderly people. Archives of Neurology, 67: 949-956, 2010.
PMC2963067  View
2010
Desikan RS, Cabral HJ, Settecase F, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Salat DH, Fiscl B, the ADNI: Automated MRI measures predict progression to Alzheimer's disease. Neurobiology of Aging. 31: 1364-1374, 2010.
PMC2902697  View
2010
Desikan RS, Sabuncu MR, Schmansky NJ, Reuter M, Cabral HJ, Hess CP, Weiner MW, Biffi A,Anderson CD, Rosand J, Salat DH, Kemper TL, Dale AM, Sperling RA, Fischl B; Selective disruptive of the cerebral neocortex in Alzheimer's disease. Plos One. 2010.
PMC2944799  View
2010
Epstein NU, Saykin AJ, Risacher SL, Gao S, Farlow MR; Alzheimer's Disease Neuroimaging Initiative (ADNI). Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. Drugs Aging. 2010 Aug 1;27(8):677-86.
PMC2951125  View
2010
Epstein NU, Saykin AJ, Riscacher SL, Gao S, Farlow MR, and the ADNI: Differences in baseline medication use in the Alzheimer Disease Neuroimaging Study: Analysis of baseline characteristics. Drugs Aging. 27: 677-686, 2010.
PMC2951125  View
2010
Evans, MC, Barnes J, Nielsen C, Kim LG, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC, and ADNI: Volume changes in Alzheimer’s disease and mild cognitive impairment: Cognitive associations. Eur Radiol, 20: 674-682, 2010.
 
2010
Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H; North American Alzheimer's Disease Neuroimaging Initiative (ADNI): Prediction of conversion from mild cognitive impairment to Alzheimer;s disease dementia based upon biomarkers and neuropsychological test performance. Neurobiology of Aging. Epub ahead of print, 2010.
 
2010
Fan M, Liu B, Zhou Y, Zhen X, Xu C, Jiang T, and the ADNI: Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults. Neuroscience Letters. 479: 332-336, 2010.
PMC2954463  View
2010
Fjell A, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Hollan D, Brewer JB, Dale AM: CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer’s disease: The Journal of Neuroscience, 30: 2088-2101, 2010.
PMC2828879  View
2010
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ et al: Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. Cerebral Cortex, 20: 2069-2079, 2010.
PMC3025722  View
2010
Fjell AM, Westlye LT, Espeseth T, Reinvang I, Dale AM, Holland D, Walhovd KB: Cortical gray matter atrophy in healthy aging connot be explained by undetected incipient cognitive disorders: A comment on Burgmans et al. Journal of Neuropsychology, 24: 258-263, 2010.
PMC3068612  View
2010
Franke K, Ziegler G, Klöppel S, Gaser C, and the Alzheimer’s Disease Neuroimaging Initiative: Estimating the age of healthy subjects from weighted MRI scans using kernel methods: Exploring the influence of various parameters. NeuroImage,50: 883-892, 2010.
 
2010
Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Loszewska I, Mecocci P, Soinnen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S: Genome wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer’s disease. Molecular Psychiatry. Epubd ahead of print, 2010.
 
2010
Gerber S, Tasdizen T, Thomas Fletcher P, Joshi S, Whitaker R; Alzheimers Disease Neuroimaging Initiative (ADNI): Manifold modeling for brain population analysis. Med Image Anal. 14: 643-653, 2010.
PMC3020141   View
2010
Greene SJ, Killiany RJ, The ADNI: Subregions of the inferiro parietal lobule are affected in the progression to Alzheimer's disease. Neurobiology of Aging. 31: 1304-1311, 2010.
PMC2907057  View
2010
Habeck C, Stern Y, ADNI: Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys. 58: 53-67, 2010.
PMC3001346  View
2010
Habeck C.G. Basics of Multivariate Analysis of Neuroimaging Data. J Vis Exp. (41). pii: 1988. doi: 10.3791/1988, 2010
PMC3074457  View
2010
Han M, Schellenberg G, and Wang L: Genome-wide association reveals genetic effects on human Ab42 and τ protein levels in cerebrospinal fluids: a case control study. BMC Neurology. 10: 1-14, 2010.
PMC2964649  View
2010
Heckemann RA, Keihaninejad S, Aljabar P, Rueckert D, Hajnal JV, Hammer A, the ADNI: Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation. Neuroimage. 51: 221-227, 2010.
 
2010
Ho AJ, Hua X, Lee S, Leow A, Yanovsky I et al: Comparing 3 Tesla and 1.5 Tesla MRI for Tracking Alzheimer’s Disease Progression with Tensor-Based Morphometry. Human Brain Mapping, 31: 499-514, 2010.
PMC2875376  View
2010
Ho AJ, Raji CA, Becker JT, Lopez OL, Kuller LH, Hua X, Lee S, Hibar D, Dinov ID, Stein JL, Jack CR, Weiner MW, Toga AW, Thompson PM, the Cardiovascular Health Study, and the ADNI: Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiology of Aging. 31: 1326-1339, 2010.
 
2010
Ho AJ, Stein JL, Hua X, Lee S, Hibar DP…. and the Alzheimer’s Disease Neuroimaging Initiative: A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. PNAS. 107: 8404-8409, 2010.
PMC2889537  View
2010
Hua X, Hibar DP, Lee S, Toga AW, Jack CR, Weiner MW, Thompson PM, and the ADNI: Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiology of Aging. 31: 1463-1480, 2010.
PMC2927200  View
2010
Hua X, Hibar DP, Lee S, Toga AW, Jack CR, Weiner MW, Thompson PM, and the ADNI: Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiology of Aging. 31: 1463-1480, 2010.
PMC2927200  View
2010
Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, and the ADNI: Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter scan intervals. Neuroimage. 51: 63-75, 2010.
PMC2846999  View
2010
Huang S, Li J, Sun L, Ye J, Fleisher A, Wu T, Chen K, Reiman E, Alzheimer's Disease Neuroimaging Initiative: Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation. Neuroimage, 50:935-949, 2010.
PMC3068623  View
2010
Ito K, Ahadleh S, Corrigan B, French J, Fullerton T et al: Disease Progression Meta-Analysis Model in Alzheimer’s Disease. Alz and Dement, 6: 39-53, 2010.
 
2010
Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.Brain. 133(11):3336-48 2010c.
PMC2965425  View
2010
Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, and the ADNI: The Alzhimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia. 6: 221-229, 2010.
PMC2920531  View
2010
Jun G, Naj AC, Beecham GW, Wang LS, Buros J…. et al: Meta-Analysis confirms CR1, CLU, and PICALM as Alzheimer’s disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 67: 1473-1484, 2010.
PMC3048805  View
2010
Karow DS, McEvoy L, Fennema-Notestine C, Hagler DJ, Jennings RG, Brewer JB, Hoh CK, Dale AM and the ADNI: Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology. 256:932-942, 2010
PMC2923729  View
2010
Kauwe JS, Cruchaga C, Bertelsen S, Mayo K, Latu W, Notwotny P, Hinrichs AL, Fagan AM, Holtzman DM ADNI, Goate AM: Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels. J Alzheimers Dis., 21: 833-842, 2010.
PMC3032214  View
2010
Kauwe JSS, Bertelson S, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Morris JC, Goate AM, and the ADNI: Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. American Journal of Medical Genetics. 153B: 955-959, 2010.
PMC2877151  View
2010
King RD, Brown B, Hwang M, Jeon T, George AT, and the ADNI: Fractal dimension analysis of the cortical ribbon in mild Alzheimer's disease. NeuroImage. 52: 471-479, 2010.
PMC2942777  View
2010
Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR, Weiner MW, Thompson PM, and the ADNI: Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiology of Aging. 31: 1429-1442, 2010.
PMC2903199  View
2010
Kruggel F, Turner J, Muftuler LT: Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. NeuroImage, 49: 2123-2133, 2010.
PMC2951115  View
2010
Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G, Reglodi D, Saykin A, Weiner M, Macciardi F, Schork N, Wallace DC, Potkin SG and ADNI: Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiology of Aging. 31: 1355-1363, 2010.
PMC2918801   View
2010
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NLS, Aisen PS, Petersen RC, Shaw LM, Torjanowski JQ, Jack Jr. CR, Weiner MW, Jagust WJ, and the ADNI: Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 75: 230, 2010.
PMC2906178  View
2010
Lemoine B, Rayburn S, Benton R: Data fusion and feature selection for Alzheimer's disease. Lec Notes in Comp Sci. 6334: 320-327, 2010.
 
2010
Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S, ADNI: Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer’s disease. Neuroimage, 51: 1345-1359, 2010.
PMC2873209  View
2010
Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR, Weiner MW, Fox NC, Ourselin S, and the Alzheimer’s Disease Neuroimaging Initiative: Robust atrophy rate measurement in Alzheimer’s disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection. NeuroImage, 50: 516-523, 2010.
PMC2828361  View
2010
Li Y, Wang Y, Xue Z, Shi F, Lin W, Shen D; Alzheimer's Disease Neuroimaging Initiative. Consistent 4D cortical thickness measurement for longitudinal neuroimaging study. Med Image Comput Comput Assist Interv. 2010;13(Pt 2):133-42.
PMC3021961  View
2010
Lorenzi M, Donohue M, Paternico D, Scarpazza C, Ostrowski S, Blin O, Irving E, Frisoni GB, the ADNI: Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment. Neurobiology of Aging. 41: 1443-1451, 2010.
 
2010
Lötjönen JMP, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G, Soininen H, Rueckert D, and the Alzheimer’s Disease Neuroimaging Initiative: Fast and robust multi-atlas segmentation of brain magnetic resonance images. NeuroImage, 49:2352-2365, 2010.
 
2010
Madsen SK, Ho AJ, Saharan PS, Toga AW, Jack CR, Weiner MW, Thompson PM, The ADNI: 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiology of Aging. 31: 1312-1325, 2010.
PMC2903198  View
2010
McDonald CR, Gharapetian L, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Holland D, Dale AM; Alzheimer's Disease Neuroimaging Initiative. Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiol Aging. Epub ahead of print, 2010.
PMC2923665  View
2010
McEvoy LK, Edland SD, Hollan D, Hagler DJ, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM, for the ADNI: Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alz Dis & Assoc Dis. 24: 269-277, 2010.
PMC2929320  View
2010
Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ, Dale AM, Brewer JB and the ADNI: Six-Month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. NeuroImage. 53: 1310-1317, 2010.
PMC2939234  View
2010
Nettiksimmons J, Harvey D, Brewer J, Carmichael O, DeCarli C, Jack CR, Petersen R, Shaw LM, Trojanowski JQ, Weiner MW, Beckett L: Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiology on Aging. 31: 1419-1428, 2010.
PMC2902683  View
2010
Okonkow OC, Alosco ML, Jerskey BA, Sweet LH, Orr BR, Tremont G, and the ADNI: Cerebral atrophy, apolipoprotein E 4, and the rate of decline in everyday function among patients with amnestic mild cognitive impairment. Alzheimer's & Dementia. 6: 404-411, 2010.
PMC2950092  View
2010
Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ, Tremont G, ADNI: Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum. Archives of Neurology. 67: 688-696, 2010.
PMC2888499  View
2010
Ott BR, Cohen RA, Gongvatana A, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD, and the ADNI: Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. Journal of Alzheimer's Disease. 20: 1387-2877, 2010.
PMC3078034  View
2010
Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR, Jr., Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW: Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization. Neurology. 74: 201-209, 2010.
PMC2809036  View
2010
Rimol LM, Agartz I, Djurovic S, Brown AA, Roddey JC et al: Sex-Dependent Association of Common Variants of Microcephaly Genes with Brain Structure. PNAS, 107: 384-388, 2010.
PMC2806758  View
2010
Risacher, SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR, Weiner MW, Saykin AJ: Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort. Neurobiology of Aging. 31: 1401-1418, 2010.
PMC2904350  View
2010
Risser L, Vialard FX, Wolz R, Holm DD, Rueckert D. Simultaneous fine and coarse diffeomorphic registration: application to atrophy measurement in Alzheimer's disease. Med Image Comput Comput Assist Interv. 2010;13(Pt 2):610-7
 
2010
Rousseau F, ADNI: A non-local approach for image super-resolution using intermodality priors. Med Image Anal. 14: 594-605, 2010.
PMC2947386  View
2010
Salas-Gonzalez D, Gorriz JM, Ramirez J, Illan IA, Lopez M, Segovia F, Chaves R and Padilla P: Feature selection using factor analysis for Alzheimer’s diagnosis using F-FDG PET images. Medical Physics. 37: 6084-6095, 2010.
PMC2994934  View
2010
Saykin, AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Kwangsik N, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR, Weiner MW, and the ADNI: Alzheimer's Disease Neuroimaging biomarkers as quatitative phenotypes: Genetics core aims, progress, and plans. Alzheimer's & Dementia. 6: 265-273, 2010.
PMC2868595  View
2010
Schneider LS, Kennedy RE, Cutter GR and ADNI: Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer disease or mild cognitive impairment does not lead to more efficient clinical trials. Alzheimer's and Dementia. 6: 367-377, 2010.
PMC2947209  View
2010
Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging. Aug; 31(8):1452-1462, 2010.
PMC2947486  View
2010
Schott JM, Bartlett JW, Fox NC, Barnes J and the ADNI: Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Annals of Neurology. 68: 825-834, 2010.
 
2010
Schuff N, Tosun D, Insel PS, Chiang GC, Truran D, Aisen PS, Jack CR, Weiner MW, the ADNI: Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiology of Aging. Epub ahead of print, 2010.
PMC3032014  View
2010
Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR, Weiner MW, the ADNI: MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. BRAIN. 132: 1067-1077, 2010.
PMC2668943  View
2010
Shen L, Kim S, Risacher S, Nho K, Waminathan S et al: Whole Genome Association Study of Brain-Wide Imaging Phenotypes for Identifying Quantitative Trait Loci in MCI and AD: A Study of the ADNI Cohort. NeuroImage, 53: 1051-1063, 2010.
PMC2892122  View
2010
Shen L, Qi Y, Kim S, Nho K, Wan J, Risacher SL, Saykin AJ; ADNI. Sparse bayesian learning for identifying imaging biomarkers in AD prediction. Med Image Comput Comput Assist Interv. 2010a;13(Pt 3):611-8.
PMC2951627  View
2010
Singh N, Fletcher PT, Preston JS, Ha L, King R, Marron JS, Wiener M, Joshi S. Multivariate statistical analysis of deformation momenta relating anatomical shape to neuropsychological measures. Med Image Comput Comput Assist Interv. 2010;13(Pt 3):529-37.
 
2010
Stein JL, Hibar DP, Madsen SK, Khamis M, McMahon KL, de Zubicaray GI, Hansel NK, Montgomery GW, Matin NG, Wright MJ, Saykin AJ, Jack CR, Jr., Weiner MW, Toga AW, Thompson PM: Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search. Mol Psych. 16:927-937, 2011.
PMC3140560  View
2010
Stein JL, Hua X, Lee S, Ho A, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, DeChairo BM, Potkin SG, Weiner MW, Thompson PM, ADNI: Voxelwise genome-wide association study (vGWAS). Neuroimage, 15: 1160-1174, 2010.
PMC2900429  View
2010
Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Faroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CJ, Jr., Weiner MW, Thompson PM, and the ADNI: Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage. 51: 542-554, 2010.
PMC2856746  View
2010
Stonnington CM, Chu C, Kloppel S, Jack CR Jr, Ashburner J, Frackowiak RS, the ADNI: Predicting clinical scores from magnetic resonance scans in Alzheimer’s disease. Neuroimage, 51: 1405-1413, 2010.
PMC2871976  View
2010
Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW, and the ADNI: Relations between brain tissue loss, CSF biomarkers, and the APOE genetic profile: A longitudinal MRI study. Neurobiology of Aging. 31: 1340-1354, 2010.
PMC2902689  View
2010
Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, Jagust W, Toga AW< Lee VM, Shaw LM, and the ADNI: Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's & Dementia. 6: 230-238, 2010.
PMC2867838  View
2010
Vemuri P, Wister HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner MW, Petersen RC, Jack CR, Jr., and on behalf of the ADNI: Effect of Apolipoprotein E in biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol. 67: 308-316, 2010.
PMC2886799  View
2010
Vounou M, Nichols TE, Montana G, and the ADNI: Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach. NeuroImage. 15: 1147-1159, 2010.
 
2010
Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Karow D, Dale AM, and the ADNI: Combining MRI, PET and CSF biomarkers in diagnosis and prognosis of Alzheimer's disease. American Journal of Neuroradiology. 31: 347-354, 2010.
PMC2821467  View
2010
Walhovd, KB, Fjell AM, Dale AM, McEvoy LK, Brewer J, Karow DS, Salmon DP, Fennema-Notestine C, the ADNI: Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiology of Aging. 31: 1107-1121, 2010.
 
2010
Wang H, Das S,Pluta J, Craige C, Altinay M, Avants B, Weiner M, Mueller S, Yushkevich P: Standing on the shoulders of giants: Improving medical image segmentation via learning based bias correction. Med Image Comput Assist Interv. 13: 105-112, 2010.
PMC3095022  View
2010
Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green RC, Walter S, Soares H, Snyder P, Siemens E, Potter W, Cole PE, Schmidt M, and the ADNI: The Alzhiemer's Disease Neurimaging Initiative: Progress report and future plans. Alzheimer's & Dementia. 6: 202-211, 2010.
PMC2927112  View
2010
Wolk DA, Dickerson BC, and the Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network fucntion in Alzheimer's disease. PNAS 107: 10256-10261, 2010.
PMC2890481  View
2010
Wolz R, Aljabar P, Hajnal JV, Hammers A, Rueckert D, and the Alzheimer’s Disease Neuroimaging Initiative: LEAP: Learning embeddings for atlas propogation. NeuroImage, 49:1316-1325, 2010.
PMC3068618  View
2010
Wolz R, Heckemann RA, Alijabar P, Hajnal JV, Hammers A, Lotjonen J, Rueckert D, and the ADNI: Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI. Neuroimage. 52: 109-118, 2010.
 
2010
Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe EM, the ADNI: Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192: 277-285, 2010.
PMC2952503  View
2010
Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T, ADNI: Effects of BDNF val66met polymorphism on brain metabolism. Molecular Neuroscience., 21: 802-807, 2010.
PMC2954459  View
2010
Yang W, Chen X, Hong X, and Huang X: ICA-Based automatic classification of magnetic resonance images from ADNI data. Lecture Notes in Computer Science. 6330: 340-347, 2010.
 
2010
Yushkevich PA, Avants BB, Das SR, Pluta J, Altinay M et al: Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global mormalization: An illustration in ADNI 3 T MRI data. NeuroImage, 50: 434-445, 2010.
PMC2823935  View
2010
Zhang T, Davatzikos C: Optimally-Discriminative Voxel-Based Analysis. Lecture Notes in Computer Science. 6362: 257-265, 2010.
 
2009
Acosta O, Bourgeat P, Zuluaga MA, Fripp J, Salvado O, Ourselin S, and ADNI: Automated voxel-based 3D cortical thickness measurement in a combined Lagrangian-Eulerian PDE approach using partial volume maps. Medical Image Analysis. 12: 730-743, 2009.
PMC306813 
2009
Brewer JB, Magda S, Airriess C, Smith ME: Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. American J of Neuroradiology. 3: 578-580. 2009.
PMC2688740  View
2009
Buerger K, Frisoni G, Uspenskaya O, Ewers M, Zetterberg H, Geroldi C, Binetti G, Johannsen P, Rossini PM, Wahlund LO, Vellas B, Blennow K, Hampel H: Validation of Alzheimer's disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Experimental Gerontology. 44: 579-585, 2009.
PMC2657833  View
2009
Calvini P, Chincarini A, Gemme G, Penco MA, Squarcla S et al: Automatic analysis of Medial Temporal Lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Medical Physics, 36: 3737-3747, 2009.
PMC2724178  View
2009
Chou YY, Lepore N, Avedissian C, Madsen SK, parishak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM, and ADNI: Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage.46: 394-410, 2009.
PMC2696357  View
2009
Chupin M, Gerardin E, Cuingnet R, Boutet C, Lemieux L, Lehericy S, Benal H, Garnero L, Colliot O, and the ADNI: Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus. 19: 579-587, 2009.
PMC2837195  View
2009
Clarkson MJ, Ourselin S, Nielsen C, Leung K, Barnes J, Whitwell JL, Gunter JL, Hill DLG, Weiner MW, Jack CR, Jr., Fox NC, and the ADNI: Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage. 47: 1506-1513, 2009.
PMC2800076  View
2009
Cruchaga C, Kauwe JS, Bertelsen S, Nowotny P, Shah AR et al: SNPs in the regulatory subunit of calcineurin are associated with CSF tau protein levels, brain mRNA levels. Alzheimer’s and Dementia, 5: 471-472, 2009.
PMC2940763  View
2009
Cruchaga C, Kauwe JS, Bertelsen S, Nowotny P, Shah AR et al: SNPs in the regulatory subunit of calcineurin are associated with CSF tau protein levels, brain mRNA levels. Alzheimer’s and Dementia, 5: 471-472, 2009.
PMC2940763  View
2009
Davatzikos C, Xu F, An Y, Fan Y, Resnick SM. (2009) Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain. 132(Pt 8):2026-35. 2009.
PMC2714059  View
2009
Evans MC, Barnes J, Nielson C, Kim, L Clegg SL et al: Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations. Eur Radiol, 71: 441-447, 2009.
 
2009
Fennema-Notestine C, Hagler DJ, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM, and ADNI: Structural Biomarkers for precilnical and mild Alzheimer's disease. Human Brain Mapping, 30: 3238-3253, 2009.
PMC2951116  View
2009
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM: One-Year Brain Atrophy Evident in Healthy Aging. The Journal of Neuroscience, 29(48):15223-15231, 2009.
PMC2827793  View
2009
Fleisher AS, Donahue M, Chen K, Brewer JB, Aisen PS, the Alzheimer’s Disease Neuroimaging Initiative: Applications of neuroimaging to disease-modification trials in Alzheimer’s disease. Behavioural Neurology, 21:129-136, 2009.
 
2009
Gunter JL, Berstein MA, Borowski BJ, Ward CP, Britson PJ, Felmlee JP, Schuff N, Weiner MW, Jack CR: Measurement of MRI performance with the ADNI phantom. Meds. Phys. 36: 2193, 2009.
PMC2754942  View
2009
Haense C, Herholz K, Jagust WJ, Heiss WD: Performance of FDG PET for detection of Alzheimer’s disease in two independent multicentre samples (NEST-DD and ADNI). Dement and Geriatric Cogn Disord, 28: 259-266, 2009.
 
2009
Hinrichs C, Sing V, Mukherjee L, Xu G, Chung MK, Johnson SC, and the Alzheimer’s Disease Neuroimagin Initiative: Spatially augmented LP boosting for AD classification with evaluations on the ADNI dataset. NeuroImage, 48:138-149, 2009.
PMC2773131  View
2009
Holland D, Brewer JB, Hagler DJ, Fenema-Nostestine C, Dale AM, and the ADNI: Subregional neuroanatomical change as a biomarker for Alzheimer's disease. PNAS. 106: 20954-20959, 2009.
PMC2791580  View
2009
Hua X, Lee S, Yanovsky I, Leow AD, Ho AJ et al: Optimizing Power to Track Brain Degeneration in Alzheimer’s Disease and Mild Cognitive Impairment with Tensor-Based Morphometry: An ADNI Study of 515 Subjects. Neuroimage, 48: 668-681, 2009.
PMC2971697  View
2009
Huang A, Abugharbieh R, Tam R and ADNI, A Hybrid Geometric-Statistical Deformable Model for Automated 3-D Segmentation in Brain MRI. IEEE, 56: 1838-1848, 2009.
PMC3068615  View
2009
Jack Jr. CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, and the Alzheimer’s Disease Neuroimaging Initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain, 132(Pt 5):1355-65, 2009.
PMC2677798  View
2009
Jagust, WJ, Landau, SM, Shaw, LM, Trojanowski, JQ, Koeppe RA, et al: Relationships between biomarkers in aging and dementia. Neurology, 73: 1193-1199, 2009.
PMC2764726  View
2009
Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multicenter PET studies. Neuroimage. 15;46(1):154-159, 2009.
 
2009
Joyner AH, Roddey CJ, Cinnamon SB, Bakken TE, Rimol LM et al: A Common MECP2 Haplotype Associates With Reduced Cortical Surface Area in Two Independent Populations. PNAS, 106: 15483-15488, 2009.
PMC2741277  View
2009
Joyner AH, Roddey CJ, Cinnamon SB, Bakken TE, Rimol LM et al: A Common MECP2 Haplotype Associates With Reduced Cortical Surface Area in Two Independent Populations. PNAS, 106: 15483-15488, 2009.
PMC2741277  View
2009
King RD, George AT, Jeon T, Hynan LS, Youn TS, Kennedy DN, Dickerson B, and the Alzheimer’s Disease Neuroimaging Initiative: Characterization of Atrophic Changes in the Cerebral Cortex Using Fractal Dimensional Analysis. Brain Imaging and Behavior, 3:154-166, 2009.
PMC2927230  View
2009
Kovacevic S, Rafii MS, Brewer BJ and the Alzheimer’s Disease Neuroimaging Initiative. High-throughput, Fully-automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders, 23(2):139-145, 2009.
PMC2688740  View
2009
Langbaum JBS, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM, and ADNI: Categorical and correlational analyses of baseline fluodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage. 45: 1107-1116, 2009.
PMC2886795  View
2009
Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, and ADNI: Alzheimer's Disease Neuroimaging Initiative: A one-year follow-up study using tensor-based morphometry degenerative rates, biomarkers and cognition. Neuroimage. 45: 645-655, 2009.
PMC2696624  View
2009
McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ, Holland D, Koyama A, Brewer JB, Dale AM, for the Alzheimer’s Disease Neuroimaging Initiative: Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology, 73: 457-465, 2009.
PMC2727145  View
2009
McEvoy L.K., Fennema-Notestine C., Cooper, J.C., Hagler, D. Jr., Holland, D., Karow D.S., Pung, C.J. Brewer J.B., Dale A.M. for the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's Disease: Quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology, 251(1):195-205, 2009.
PMC2663582  View
2009
Misra C, Fan Y, Davatzikos C: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. Neuroimage. 44: 1415-1422, 2009.
PMC2648825  View
2009
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM and the ADNI: Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 45: S3-15, 2009.
PMC2733354  View
2009
Morra JH, Zhuwen T, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM, and ADNI: Automated 3D Mapping of Hippocampal Atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Human Brain Mapping. 30: 2766-2788, 2009.
PMC2733926  View
2009
Morra JH, Zhuwen T, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM, and ADNI: Automated 3D Mapping of Hippocampal Atrophy and its clinical correlates in 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 45: S3-S15, 2009.
PMC2733354  View
2009
Mortamet B, Bernstein MA, Jack CR, Jr., Gunter JL, Ward C, Britson PJ, Meuli R, Thiran J-P, Krueger G, and the ADNI: Automatic quality assessment in structural brain magnetic resonance imaging. Magnetic Resonance Imaging. 62: 365-372, 2009.
PMC2780021  View
2009
Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner MW, Macciardi F for the ADNI: Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS ONE. 4: e6501, 2009.
PMC2719581  View
2009
Qiu A, Fennema-Notestine C, Dale AM, Miller MI. Alzheimer's Disease Neuroimaging Initiative. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroimage. 45(3):656-61, 2009.
PMC2847795  View
2009
Querbes O, Aubry F, Pariente J, Lotterie J-A, Demonet JF, Duret V, Puel M, Berry I, Fort J-C, Celsis P, ADNI: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. BRAIN. 132: 2036-2047, 2009.
PMC2714060  View
2009
Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC, and the Alzheimer’s Disease Neuroimaging Initiative: Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort. Current Alzheimer Research, 6:347-361, 2009.
PMC2764863  View
2009
Shaw LM, Vanderstichele H, Knapnik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VMY, Trojanowski JQ and the ADNI: Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Annals of Neurology. 65: 403-413, 2009.
PMC2696350  View
2009
Vemuri P, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, Jack Jr CR and the Alzheimer’s Disease Neuroimaging Initiative: Serial MRI and CSF biomarkers in normal, MCI and AD. Brain, 132:1355-1365, 2009.
PMC2905929  View
2009
Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ et al: MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology, 73: 294-301, 2009.
PMC2715214  View
2009
Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner M, Knopman DS, Petersen RC, Jack Jr CR, and the Alzheimer’s Disease Neuroimaging Initiative. MRI and CSF biomarkers in normal, MCI, AD: Diagnostic discrimination and cognitive correlations. Neurol., 73:287-293, 2009a.
PMC2715210  View
2008
Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DLG, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, DeCaril C, Jack CR, Fox NC, on behalf of the ADNI Study: Intensity non-uniformity correction using N3 on 3_T scanners with multichannel phased array coils. Neuroimage. 39: 1752-1762, 2008.
PMC2562663  View
2008
Brewer JB, Magda S, Airriess C, Smith ME: Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. American J of Neuroradiology. 3: 578-580. 2009.
PMC2688740  View
2008
Cronk BB, Johnson DK, Burns JM, and the Alzheimer’s Disease Neuroimaging Initiative: Body Mass Index and Cognitive Decline in Mild Cognitive Impairment. Alzheimer’s Disease & Associated Disorders, 24: 126-130, 2010.
PMC3068614  View
2008
Fennema-Notestine C, Hagler DJ, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM, and ADNI: Structural Biomarkers for precilnical and mild Alzheimer's disease. Human Brain Mapping, 30: 3238-3253, 2009.
PMC2951116  View
2008
Frisoni GB, Henneman WJP, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Biennow K, Waldemar G, Johannsen P, Wahlund L-O, Zito G, Rossini PM, Winblad B, Barkhof F, and the ADNI: The pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI) of the European Alzheimer's Disease Consortium. Alzheimers & Dementia. 4: 255-264, 2008.
PMC2657833  View
2008
Gunter, JL, Borowski B, Britson P, Berstein M, Ward C, Felmlee J, Schuff N, Weiner M, Jack C: Alzheimer's Disease Neuroimaging Initiative phantom and scanner longitudinal performance. Alzheimer's and Dementia. 4: T370, 2008.
 
2008
Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR, Berstein MA, Britson PJ, Ward CP, Whitewell JL, Borowski B, Felsiher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM, and ADNI: 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensore-based morphometry. Neuroimage. 41: 19-34, 2008.
PMC2556222  View
2008
Hua, X, Leow AD, parishak N, Lee S, Chiang MC, Toga AW, Jack CR, Weiner MW, Thompson PM, and ADNI: Tensor-based morphometry as a neurimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects. Neuroimage. 43: 458-469, 2008.
 
2008
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ, and the Alzheimer's Disease Neuroimaging Initiative. Intensity non-uniformity correction using N# on 3-T scanners with multichannel phased array coils Brain. 132: 1310-1323, 2008.
PMC2677792  View
2008
Shaw LM. PENN biomarker core of the Alzheimer’s Disease Neuroimaging Initiative. Neurosignals, 16(1):19-23, 2008.
PMC2696349  View
2008
Tsolaki MN, Papaliagkas VT, Jones R, Touchon J, Spiru L, Visser PJ, Verhey F, and DESCRIPA Study Group: Medication in patients with mild cognitive impairment in Europe: The development of screening guidelines and clinical criteria of predementia Alzheimer's disease (DESCRIPA) study. Alzheimer's and Dementia. 4: T683-T684, 2008.
PMC2821431  View
2008
Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ et al: MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology, 73: 294-301, 2009.
PMC2715214  View
2007
Fletcher PT, Powell S, Foster NL, Joshi SC: Quantifying metabolic asymmetry modulo structure in Alzheimer's disease. Inf Process Med Imaging. 20:446-457, 2007.
 
2006
Leow AD, Klunder AD, Jack CR, Jr., Toga AW, Dale AM, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Whitwell JL, Borowski BJ, Fleisher AS, Fox NC, Harvey D, Kornak J, Schuff N, Studholme C, Alexander GE, Weiner MW, Thompson PM, for the ADNI Prepatory Phase Study: Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NeuroImage. 31: 627-640, 2006.
PMC1941663  View
2005
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Becket L: Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimer's Dementia, 1: 55-66, 2005.
PMC1864941  View
 
[ Back ]